Scheme of Arrangement Becomes Effective - Seite 2

Allkem Shareholders should be aware that Arcadium Lithium Shares will not trade on a deferred settlement basis on the NYSE. Accordingly, Allkem Shareholders who will receive Arcadium Lithium Shares under the Scheme (being eligible Allkem Canadian branch register shareholders who do not validly elect to receive Arcadium Lithium CDIs, and eligible Allkem principal register shareholders who validly elect to receive Arcadium Lithium Shares) will not be able to trade their Scheme Consideration until after commencement of trading of Arcadium Lithium Shares on the NYSE (which is expected to commence at 9:30 am (New York time) on the Implementation Date).

Scheme timetable

The key dates remaining for the Transaction are set out below.

Event		Date / time
Suspension of Allkem Shares from trading on ASX		Close of trading on 21 December 2023 (AEDT)
Suspension of Allkem Shares from trading on TSX		4:00 pm (Toronto time) / 9:00 pm (UTC) on 21 December 2023
Arcadium Lithium CDIs to commence trading on ASX on a deferred settlement basis		22 December 2023
Record Date for determining entitlements to receive Scheme Consideration		7:00 pm (AEDT) on 27 December 2023
Scheme Implementation Date		4 January 2024
US Merger Effective Time		4 January 2024 (New York time)
Last day of deferred settlement trading for Arcadium Lithium CDIs		4 January 2024
Arcadium Lithium Shares anticipated to commence trading on NYSE		9:30 am (New York time) on 4 January 2024
Despatch of holding statements for Arcadium Lithium CDIs		5 January 2024
Arcadium Lithium CDIs to commence trading on ASX on a normal settlement basis		10:00am (AEDT) on 5 January 2024
Expected date for Allkem to be delisted from ASX		Close of trading on 5 January 2024 (AEDT)
Expected date for Allkem to be delisted from TSX		Close of trading on 5 January 2024 (Toronto time)
First settlement of deferred settlement and normal settlement trading of Arcadium Lithium CDIs		9 January 2024